Diabetes, Vol 46, Issue 6 1017-1024, Copyright © 1997 by American Diabetes Association

ARTICLES

Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia

SE Nikoulina, TP Ciaraldi, L Abrams-Carter, S Mudaliar, KS Park and RR Henry
Department of Medicine, University of California, San Diego, and the Veterans Affairs Medical Center 92161, USA.

Human skeletal muscle cultures (HSMCs) from type II diabetic subjects were used to determine whether metabolic abnormalities such as hyperglycemia or hyperinsulinemia contribute to the defective muscle glycogen synthase (GS) activity present in this disorder. Following approximately 6 weeks of growth, diabetic cultures were fused for 4 days in normal, hyperglycemia, or hyperinsulinemia medium. Fusion of diabetic HSMCs in hyperglycemia medium (20 mmol/l vs. 5.5 mmol/l) had no effect on GS fractional velocity (FV) or mRNA levels, but impaired acute insulin-stimulation of glycogen synthesis and GS activity at 0.1 mmol/l glucose-6-phosphate, and reduced GS protein content by approximately 15% (P < 0.05). Fusion of diabetic muscle cultures in hyperinsulinemia medium (30 micromol/l vs. 22 pmol/l) improved basal GS activity, increasing the reduced GS FV by approximately 50% (P < 0.05), and decreasing the elevated Km(0.1) (half-maximal substrate concentration) by approximately 47% (P < 0.05). Hyperinsulinemia also significantly increased (P < 0.05) the reduced GS mRNA and protein levels of diabetic muscle to levels similar to that in nondiabetic subjects. In contrast to the improvements in the basal state, hyperinsulinemia completely abolished acute insulin responsiveness of GS activity and glycogen synthesis in muscle of type II diabetic subjects. The combination of hyperinsulinemia and hyperglycemia produced effects on both basal and insulin-responsive GS FV and mRNA similar to hyperinsulinemia alone, but hyperinsulinemia prevented hyperglycemia's effect of lowering GS protein and glycogen synthesis. We concluded that, in diabetic muscle, hyperinsulinemia may serve to partially compensate for the impaired basal GS activity and for the adverse effects of hyperglycemia on GS protein content, activity, and glycogen formation by both pre- and posttranslational mechanisms. Despite these beneficial effects, hyperinsulinemia also induces severe impairment of insulin-stimulated GS activity and glycogen formation, which may contribute to acquired muscle insulin resistance of type II diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. A. McIntyre, R. Halse, S. J. Yeaman, and M. Walker Cultured Muscle Cells from Insulin-Resistant Type 2 Diabetes Patients Have Impaired Insulin, but Normal 5-Amino-4-Imidazolecarboxamide Riboside-Stimulated, Glucose Uptake J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3440 - 3448. [Abstract] [Full Text] [PDF]

				M. Gaster, A. C. Rustan, V. Aas, and H. Beck-Nielsen Reduced Lipid Oxidation in Skeletal Muscle From Type 2 Diabetic Subjects May Be of Genetic Origin: Evidence From Cultured Myotubes Diabetes, March 1, 2004; 53(3): 542 - 548. [Abstract] [Full Text] [PDF]

				B. Plotkin, O. Kaidanovich, I. Talior, and H. Eldar-Finkelman Insulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3 J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 974 - 980. [Abstract] [Full Text] [PDF]

				S. E. Nikoulina, T. P. Ciaraldi, S. Mudaliar, L. Carter, K. Johnson, and R. R. Henry Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle Diabetes, July 1, 2002; 51(7): 2190 - 2198. [Abstract] [Full Text] [PDF]

				M. Gaster, I. Petersen, K. Hojlund, P. Poulsen, and H. Beck-Nielsen The Diabetic Phenotype Is Conserved in Myotubes Established From Diabetic Subjects: Evidence for Primary Defects in Glucose Transport and Glycogen Synthase Activity Diabetes, April 1, 2002; 51(4): 921 - 927. [Abstract] [Full Text] [PDF]

				S. E. Nikoulina, T. P. Ciaraldi, L. Carter, S. Mudaliar, K. S. Park, and R. R. Henry Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4307 - 4314. [Abstract] [Full Text] [PDF]

				X. Huang, A. Vaag, M. Hansson, J. Weng, E. Laurila, and L. Groop Impaired Insulin-Stimulated Expression of the Glycogen Synthase Gene in Skeletal Muscle of Type 2 Diabetic Patients Is Acquired Rather Than Inherited J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1584 - 1590. [Abstract] [Full Text]

				M. Roques and H. Vidal A Phosphatidylinositol 3-Kinase/p70 Ribosomal S6 Protein Kinase Pathway Is Required for the Regulation by Insulin of the p85alpha Regulatory Subunit of Phosphatidylinositol 3-Kinase Gene Expression in Human Muscle Cells J. Biol. Chem., November 26, 1999; 274(48): 34005 - 34010. [Abstract] [Full Text] [PDF]

				M. Christopher, F. L. Hew, M. Oakley, C. Rantzau, and F. Alford Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone Therapy J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1668 - 1681. [Abstract] [Full Text]